Immuron (IMRN) Exchange Rate Effect (2016 - 2024)
Immuron's (IMRN) quarterly Exchange Rate Effect came in at $39482.6 in Q4 2024, up 183.31% year-on-year from $13936.4 in Q1 2024, and up 183.31% quarter-over-quarter from -$47394.7 in Q4 2023.
Immuron (IMRN) Exchange Rate Effect (2016 - 2024) Analysis & Trends
Immuron's Exchange Rate Effect history runs 9 years deep, the most recent figure standing at $39482.6 for Q4 2024.
- On a quarterly basis, Exchange Rate Effect rose 183.31% year-over-year to $39482.6 in Q4 2024; TTM through Dec 2024 was -$535877.9, a 57.87% increase from a year earlier, with the FY2025 full-year figure at $10825.0, down 78.04% from the prior year.
- Exchange Rate Effect improved to $39482.6 in Q4 2024 per IMRN's latest filing, from -$47394.7 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $39482.6 in Q4 2024 and bottomed at -$696559.0 in Q4 2020.
- The 5-year median for Exchange Rate Effect is -$47394.7 (2023), against an average of -$246487.4.
- Across the five-year window, Exchange Rate Effect tumbled 3238.36% in 2020 and soared 183.31% in 2024, its largest moves.
- Year by year, Exchange Rate Effect stood at -$696559.0 in 2020, then increased by 26.8% to -$509893.8 in 2021, then soared by 96.46% to -$18072.0 in 2022, then plunged by 162.25% to -$47394.7 in 2023, then surged by 183.31% to $39482.6 in 2024.
- Per Business Quant, the three latest IMRN Exchange Rate Effect figures stand at $39482.6 (Q4 2024), -$47394.7 (Q4 2023), and -$18072.0 (Q4 2022).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 19.32 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Immuron | 255.19 Mn | 243.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 39,482.63 |
| Dec 31, 2024 | 39,482.63 |
| Dec 31, 2023 | -47,394.71 |
| Dec 31, 2023 | -47,394.71 |
| Dec 31, 2022 | -18,072.00 |
| Dec 31, 2022 | -18,072.00 |
| Dec 31, 2021 | -509,893.78 |
| Dec 31, 2021 | -509,893.78 |
| Dec 31, 2020 | -696,559.00 |
| Dec 31, 2020 | -696,559.00 |
| Dec 31, 2019 | 22,195.00 |
| Dec 31, 2019 | 22,195.00 |
| Dec 31, 2018 | -112,270.00 |
| Dec 31, 2018 | -112,270.00 |
| Dec 31, 2017 | 22,040.59 |
| Dec 31, 2017 | 22,040.59 |
| Dec 31, 2016 | 110.83 |
| Dec 31, 2016 | 110.83 |